DE2605656A1 - Pharmazeutische zubereitungen in tablettenform - Google Patents

Pharmazeutische zubereitungen in tablettenform

Info

Publication number
DE2605656A1
DE2605656A1 DE19762605656 DE2605656A DE2605656A1 DE 2605656 A1 DE2605656 A1 DE 2605656A1 DE 19762605656 DE19762605656 DE 19762605656 DE 2605656 A DE2605656 A DE 2605656A DE 2605656 A1 DE2605656 A1 DE 2605656A1
Authority
DE
Germany
Prior art keywords
tablet
tablet according
sulfonamide
particle size
disintegration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762605656
Other languages
German (de)
English (en)
Inventor
David Harden
John Spence
Allan John Torode
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2605656A1 publication Critical patent/DE2605656A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19762605656 1975-02-13 1976-02-12 Pharmazeutische zubereitungen in tablettenform Withdrawn DE2605656A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6174/75A GB1533243A (en) 1975-02-13 1975-02-13 Tablet formulation

Publications (1)

Publication Number Publication Date
DE2605656A1 true DE2605656A1 (de) 1976-08-26

Family

ID=9809772

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762605656 Withdrawn DE2605656A1 (de) 1975-02-13 1976-02-12 Pharmazeutische zubereitungen in tablettenform

Country Status (14)

Country Link
JP (1) JPS51106711A (xx)
BE (1) BE838507A (xx)
CA (1) CA1052267A (xx)
DE (1) DE2605656A1 (xx)
DK (1) DK57376A (xx)
FI (1) FI760340A (xx)
FR (1) FR2300550A1 (xx)
GB (1) GB1533243A (xx)
HU (1) HU171201B (xx)
IE (1) IE42952B1 (xx)
IL (1) IL49024A (xx)
NL (1) NL7601423A (xx)
SE (1) SE7601564L (xx)
ZA (1) ZA76829B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
NL9220009A (nl) * 1991-01-30 1993-11-01 Wellcome Found In water-dispergeerbare tabletten.
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1460302A (en) * 1973-05-23 1977-01-06 Wellcome Found Tablet formulation
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation

Also Published As

Publication number Publication date
IE42952B1 (en) 1980-11-19
GB1533243A (en) 1978-11-22
IL49024A0 (en) 1976-04-30
FR2300550B1 (xx) 1979-09-21
FI760340A (xx) 1976-08-14
FR2300550A1 (fr) 1976-09-10
SE7601564L (sv) 1976-08-16
CA1052267A (en) 1979-04-10
IL49024A (en) 1979-03-12
ZA76829B (en) 1977-09-28
NL7601423A (nl) 1976-08-17
AU1110876A (en) 1977-08-18
IE42952L (en) 1976-08-13
HU171201B (hu) 1977-11-28
JPS51106711A (xx) 1976-09-21
BE838507A (fr) 1976-08-12
DK57376A (da) 1976-08-14

Similar Documents

Publication Publication Date Title
DE69311395T2 (de) Sphäroidische Arzneimittelformulierung
DE69732312T2 (de) Schnellzerfallendes Granulate von einem synthetischen Süssstoff enthaltend Kieselsäure und/oder Siliciumdioxid
DE3887179T2 (de) Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
EP0108898B1 (de) Neue orale Mopidamolformen
DE68916983T2 (de) Verfahren zur Herstellung eines pharmazeutischen Granulats.
DE3688674T2 (de) Hydroxypropylcelluloseether enthaltende Mittel mit verzögerter Wirkstoffabgabe.
CH639845A5 (en) Solid depot pharmaceutical preparations and process for their production
DE60224056T2 (de) Antazide und laxative magnesiumoxid-tablette
DE2200778B2 (de) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
DE1467781A1 (de) Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
DE2706660A1 (de) Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung
DE1492253A1 (de) Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung
DE60129515T2 (de) Basismaterial zur trockenen Direkttablettierung enthaltend niedrig substituierte Hydroxypropylcellulose
DE2605656A1 (de) Pharmazeutische zubereitungen in tablettenform
DE3150557C2 (xx)
CH658787A5 (de) Pharmazeutische praeparate mit gleichbleibenden elutionseigenschaften.
DE3873011T2 (de) Pharmazeutische zusammensetzung, enthaltend piperidinalkanolderivate.
DE2050701C3 (de) Verwendung eines pulverförmigen Celluloseäthers als Hilfsstoff zur Herstellung von leicht zerfallbaren festen Arzneiformen
DE1925919C3 (de) Tablette für die gleichmäßige Freisetzung eines Arzneimittels
CH618432A5 (en) Process for the preparation of a 2,4-diamino-5-benzylpyrimidine intended for the production of tablets
DE3942131C2 (de) Pharmazeutisches Trimebutin-haltiges Präparat mit verlängerter Wirkstoff-Freisetzung und Verfahren zur Herstellung
DE1617638A1 (de) Tablettenbindemittel
DE68907609T2 (de) Arzneimittelzusammensetzung.
DE1931910A1 (de) Verfahren zur Herstellung von festen Arzneizubereitungen mit gesteuerter Resorption

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee